Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	584.03B
Revenue (ttm)	810.68B
Net Income (ttm)	26.03B
Shares Out	12.18M
EPS (ttm)	2,134.05
PE Ratio	22.47
Forward PE	n/a
Dividend	525.00 (1.09%)
Ex-Dividend Date	Aug 20, 2025

Volume	60,308
Average Volume	47,630
Open	48,150
Previous Close	47,950
Day's Range	48,150 - 50,500
52-Week Range	23,050 - 54,900
Beta	1.05
RSI	57.60
Earnings Date	Aug 1, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.